Download Files:
ANEB-001
SKU
HY-148176-Get quote
Category Reference compound
Tags Cannabinoid Receptor, GPCR/G Protein;Neuronal Signaling, Neurological Disease
Products Details
Product Description
– ANEB-001 is an orally active CB1 inhibitor, can be used to research acute cannabinoid intoxication[1].
Web ID
– HY-148176
Shipping
– Room temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C22H24ClF3N2O2
References
– [1]Joseph Fenton Lawler, et al. Formulations and methods for treating acute cannabinoid overdose. US11141404B1
CAS Number
– 791848-71-0
Molecular Weight
– 440.89
SMILES
– CC(C)(C)NC(N(C1)CC1O[C@H](C2=CC=C(C=C2)Cl)C3=C(C=CC=C3)C(F)(F)F)=O
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Cannabinoid Receptor
Isoform
– CB1
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.